KA87 Neonatal hyperbilirubinaemia
International Classification of Diseases for Mortality and Morbidity Statistics, 11th Revision, v2024-01
A condition characterised as an increased level of bilirubin above 85 µmol/l (5 mg/dL) which manifests as yellowing of the eyes, skin, and other tissues of a newborn due to excessive break-down of red blood cells for any other reason not classified elsewhere.
exclusions
code elsewhere
sections/codes in this section (KA87-KA87)
- Neonatal hyperbilirubinaemia due to swallowed maternal blood (KA87.0)
- Neonatal hyperbilirubinaemia due to enzymatic defect in bilirubin degradation (KA87.1)
- Neonatal hyperbilirubinaemia due to breast milk inhibitor of bilirubin conjugation (KA87.2)
- Neonatal hyperbilirubinaemia due to total parenteral nutrition (KA87.3)
- Neonatal hyperbilirubinaemia due to drugs or toxins transmitted from mother (KA87.4)
- Neonatal hyperbilirubinaemia due to drugs or toxins given to newborn (KA87.5)
- Neonatal hyperbilirubinaemia from other or unspecified hepatocellular damage (KA87.6)
- Other specified neonatal hyperbilirubinaemia (KA87.Y)
- Neonatal hyperbilirubinaemia, unspecified (KA87.Z)
Thank you for choosing Find-A-Code, please Sign In to remove ads.